Alan James

4.8k total citations · 1 hit paper
98 papers, 3.1k citations indexed

About

Alan James is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Alan James has authored 98 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Physiology, 66 papers in Pulmonary and Respiratory Medicine and 11 papers in Immunology. Recurrent topics in Alan James's work include Asthma and respiratory diseases (64 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (32 papers) and Respiratory and Cough-Related Research (26 papers). Alan James is often cited by papers focused on Asthma and respiratory diseases (64 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (32 papers) and Respiratory and Cough-Related Research (26 papers). Alan James collaborates with scholars based in Australia, Canada and United Kingdom. Alan James's co-authors include John Elliot, John W. Upham, Peter G. Gibson, Christine Jenkins, Michael J. Abramson, Peter B. Noble, Paul N. Reynolds, Ian A. Yang, Sandra Hodge and Jodie L. Simpson and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Alan James

91 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial

2017 446 citations Peter G. Gibson, Ian A. Yang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alan James Australia	29	2.1k	1.8k	486	409	265	98	3.1k
Markku M. Nieminen Finland	28	1.3k 0.6×	1.4k 0.8×	254 0.5×	263 0.6×	317 1.2×	62	2.9k
Hisako Matsumoto Japan	39	2.9k 1.4×	3.3k 1.9×	421 0.9×	583 1.4×	667 2.5×	195	5.0k
G H Koëter Netherlands	32	2.3k 1.1×	2.7k 1.5×	324 0.7×	295 0.7×	317 1.2×	91	4.0k
Steven R. White United States	37	1.4k 0.6×	1.3k 0.8×	690 1.4×	924 2.3×	317 1.2×	112	3.5k
Celeste Porsbjerg Denmark	32	2.9k 1.4×	2.1k 1.2×	603 1.2×	246 0.6×	351 1.3×	207	3.8k
Bradley E. Chipps United States	42	4.5k 2.1×	3.9k 2.2×	611 1.3×	214 0.5×	586 2.2×	239	6.0k
Tim Harrison United Kingdom	27	1.6k 0.7×	1.5k 0.9×	214 0.4×	139 0.3×	152 0.6×	70	2.2k
Iolo Doull United Kingdom	28	1.0k 0.5×	1.5k 0.8×	221 0.5×	207 0.5×	204 0.8×	77	2.3k
John G. Mastronarde United States	27	1.5k 0.7×	1.4k 0.8×	311 0.6×	79 0.2×	241 0.9×	55	2.4k
John A. Burgess Australia	32	1.4k 0.7×	679 0.4×	205 0.4×	218 0.5×	301 1.1×	78	3.1k

Countries citing papers authored by Alan James

Since Specialization

Citations

This map shows the geographic impact of Alan James's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan James with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan James more than expected).

Fields of papers citing papers by Alan James

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan James. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan James. The network helps show where Alan James may publish in the future.

Co-authorship network of co-authors of Alan James

This figure shows the co-authorship network connecting the top 25 collaborators of Alan James. A scholar is included among the top collaborators of Alan James based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan James. Alan James is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhu, Kun, Michael Hunter, John P. Walsh, et al.. (2025). Cross-sectional and longitudinal associations of DXA-measured body composition with lung function in middle-aged Australians: The Busselton Healthy Ageing Study. Obesity Research & Clinical Practice. 19(3). 254–260.

Zhu, Kun, Michael Hunter, Alan James, Ee Mun Lim, & John P. Walsh. (2023). Relationships between longitudinal changes in body composition and bone mineral density in middle-to-older aged Australians. Osteoporosis International. 34(9). 1601–1611. 4 indexed citations

Zhu, Kun, Michael Hunter, Jennie Hui, et al.. (2022). Longitudinal Stability of Vitamin D Status and Its Association With Bone Mineral Density in Middle-aged Australians. Journal of the Endocrine Society. 7(2). bvac187–bvac187. 7 indexed citations

Lowe, Adrian J., Jennifer L. Perret, E. Haydn Walters, et al.. (2022). Impact of lifetime body mass index trajectories on the incidence and persistence of adult asthma. European Respiratory Journal. 60(3). 2102286–2102286. 9 indexed citations

Brown, Nathan J., Brett G. Toelle, Guy B. Marks, et al.. (2021). Normal limits for oscillometric bronchodilator responses and relationships with clinical factors. ERJ Open Research. 7(4). 439–2021. 12 indexed citations

Hunter, Michael, Matthew Knuiman, Arthur W. Musk, et al.. (2021). Prevalence and patterns of multimorbidity in Australian baby boomers: the Busselton healthy ageing study. BMC Public Health. 21(1). 1539–1539. 17 indexed citations

Bui, Dinh, Àlvar Agustí, E. Haydn Walters, et al.. (2021). Lung function trajectory and biomarkers in the Tasmanian Longitudinal Health Study. ERJ Open Research. 7(3). 20–2021. 14 indexed citations

Kanabar, Varsha, Yanira Riffo‐Vasquez, Zainab Mohamed, et al.. (2021). Platelets Independently Recruit into Asthmatic Lungs and Models of Allergic Inflammation via CCR3. American Journal of Respiratory Cell and Molecular Biology. 64(5). 557–568. 21 indexed citations

Maltby, Steven, Peter G. Gibson, Helen K. Reddel, et al.. (2020). Severe Asthma Toolkit: an online resource for multidisciplinary health professionals—needs assessment, development process and user analytics with survey feedback. BMJ Open. 10(3). e032877–e032877. 11 indexed citations

10.

O’Neill, Ciarán, Peter G. Gibson, Liam G. Heaney, et al.. (2020). The cost-effectiveness of azithromycin in reducing exacerbations in uncontrolled asthma. European Respiratory Journal. 57(2). 2002436–2002436. 4 indexed citations

11.

Jones, Robyn L., et al.. (2020). Airway narrowing and response to simulated deep inspiration in bronchial segments from subjects with fixed airflow obstruction. Journal of Applied Physiology. 128(4). 757–767. 3 indexed citations

12.

Elliot, John, Graham M. Donovan, Kimberley C. W. Wang, et al.. (2019). Fatty airways: implications for obstructive disease. European Respiratory Journal. 54(6). 1900857–1900857. 78 indexed citations

13.

Taylor, Steven, Lex E. X. Leong, Fredrick M. Mobegi, et al.. (2019). Long-Term Azithromycin Reduces Haemophilus influenzae and Increases Antibiotic Resistance in Severe Asthma. American Journal of Respiratory and Critical Care Medicine. 200(3). 309–317. 128 indexed citations

14.

Gibson, Peter G., Ian A. Yang, John W. Upham, et al.. (2019). Efficacy of azithromycin in severe asthma from the AMAZES randomised trial. ERJ Open Research. 5(4). 56–2019. 33 indexed citations

15.

Gibson, Peter G., Ian A. Yang, John W. Upham, et al.. (2017). Azithromycin Reduces Exacerbations In Adults With Persistent Symptomatic Eosinophilic Asthma. Respirology. 195. 24–24. 1 indexed citations

16.

Simpson, Jodie L., Ian A. Yang, John W. Upham, et al.. (2015). Sputum and serum periostin levels are associated with, but do not predict sputum eosinophil proportion in severe asthma. American Journal of Respiratory and Critical Care Medicine. 191. 2 indexed citations

17.

Zhang, Xin, Jodie L. Simpson, Heather Powell, et al.. (2014). Full blood count parameters for the detection of asthma inflammatory phenotypes. Clinical & Experimental Allergy. 44(9). 1137–1145. 177 indexed citations

18.

Simpson, Joe Leigh, Ian A. Yang, Paul N. Reynolds, et al.. (2013). Alternatives to Induced Sputum for Identifying Patients with Eosinophilic Asthma. Adelaide Research & Scholarship (AR&S) (University of Adelaide). 2 indexed citations

19.

James, Alan, Robyn L. Jones, Michael J. Abramson, et al.. (2013). Distribution of increased airway smooth muscle thickness and airway inflammation in asthma. European Respiratory Journal. 42(Suppl 57). P570–P570.

20.

James, Alan, John Elliot, Robyn L. Jones, et al.. (2012). Airway Smooth Muscle Hypertrophy and Hyperplasia in Asthma. American Journal of Respiratory and Critical Care Medicine. 185(10). 1058–1064. 233 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact